Paradigm Therapeutics

Mt Pleasant, United States

Paradigm Therapeutics is a biopharmaceutical company that develops therapies for rare diseases.

$25.1M raised

May 2025

Venture - Series Unknown

Biopharma Manufacturing Pharmaceutical

Top Investors

Eshelman Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Paradigm Therapeutics

How much funding has Paradigm Therapeutics raised?

Paradigm Therapeutics has raised $25.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2025.

Who are Paradigm Therapeutics's investors?

Paradigm Therapeutics's investors include Eshelman Ventures.

Where is Paradigm Therapeutics headquartered?

Paradigm Therapeutics is headquartered in Mt Pleasant, United States.

What does Paradigm Therapeutics do?

Paradigm Therapeutics is a biopharmaceutical company that develops therapies for rare diseases.

What stage is Paradigm Therapeutics at?

Paradigm Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 6, 2025.

MLA

"Paradigm Therapeutics — Funding & Investors." VCBacked, May 6, 2025, https://www.vcbacked.co/company/paradigm-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2025). Paradigm Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/paradigm-therapeutics

Wikipedia (cite web)

{{cite web |title=Paradigm Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/paradigm-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 6, 2025.